2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation 2026

View at publisher
Authors: Roger S. Blumenthal, Pamela B. Morris, Mario Gaudino, Heather M. Johnson, Timothy S. Anderson, Vera A. Bittner, Ron Blankstein, LaPrincess C. Brewer, Leslie Cho, Sarah D. de Ferranti, Eugenia Gianos, Ty J. Gluckman
+50 more Kristen Gradney, Ijeoma Isiadinso, Donald M Lloyd-Jones, Joel C. Marrs, Seth S. Martin, Kellie McLain, Laxmi S. Mehta, Samia Mora, Wudeneh Mulugeta, Pradeep Natarajan, Ann Marie Navar, Carl E. Orringer, Tamar S. Polonsky, Harmony R. Reynolds, Joseph J. Saseen, Michael D. Shapiro, Daniel E. Soffer, Sheila Tynes, Chloé Davidson Villavaso, Salim S. Virani, John T. Wilkins, ANAND ROHATGI SR., Samuel M. Kim, Karen P. Alexander, Cheryl Anderson, Catherine P. Benziger, Dave L. Dixon, Daniel Duprez, Keith C. Ferdinand, Anne C. Goldberg, Parag Joshi, Joshua W. Knowles, Carl (Chip) J. Lavie Jr, Jane A. Linderbaum, John W. McEvoy, Anurag Mehta, C. Noel Bairey Merz, Vijay Nambi, Ariela R. Orkaby, Jessica M. Peña, Robert Rosenson, Janelle Ruisinger, Sigrid Sandner, Stacey L. Schott, Laurence Sperling, Neil J. Stone, Peter Toth, Adam L. Ware, Seamus P. Whelton, James Young
DOI: 10.1161/cir.0000000000001423
Cited by: 81
References: 752

Abstract

AIM: The "2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia" retires and replaces the "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol." METHODS: A comprehensive literature search was conducted from October 2024 to December 2024 to identify clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. STRUCTURE: The focus of this clinical practice guideline is to address the evaluation, management, and monitoring of individuals with dyslipidemias, including high blood cholesterol, hypertriglyceridemia, and elevated lipoprotein(a).

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Diabetes Cardiovascular Risks and Lipoproteins Natural Products and Biological Research

Publication details

Journal / source
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
153
Issue
17
Pages
e1154–e1276
Publication date
13 March 2026
Language
EN